In light of a global rise in obesity and type 2 diabetes, non-alcoholic fatty liver disease
(NAFLD) and non-alcoholic steatohepatitis (NASH) represent an increasingly important …

Background & Aims Biannual ultrasound has poor sensitivity for hepatocellular carcinoma
(HCC) screening. MRI is accurate for the detection of HCC, but a complete MRI is not …

Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver
disease and affects nearly a quarter of the global population. The objective of this work was …

Background & Aims Several models have recently been developed to predict risk of
hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). Our aims were to …

Hepatocellular carcinoma (HCC) mortality remains high primarily due to late diagnosis as a
consequence of failed early detection. Professional societies recommend semi‐annual HCC …

To detect potentially curable hepatocellular carcinoma (HCC), clinical practice guidelines
recommend semiannual surveillance US of the liver in adult patients at risk for developing …

Objectives The primary objective was to compare the performance of 3 different abbreviated
MRI (AMRI) sets extracted from a complete gadoxetate-enhanced MRI obtained for …

Hepatocellular carcinoma (HCC) is a leading cause of cancer‐related mortality worldwide.
Early detection of HCC enables patients to avail curative therapies that can improve patient …

Abstract Background & Aims We aimed to compare the performance of gadoxetic acid‐
enhanced abbreviated MRI (AMRI)‐based surveillance and ultrasound‐only surveillance in …

Simple Summary Hepatocellular carcinoma (HCC) is the fifth most common cancer
worldwide and the second most common oncological reason for death. Liver resection and …